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We present a general approach for the targeting and imaging of cancer
cells using dendrimer-entrapped gold nanoparticles (Au DENPs). Au
DENPs were found to be able to covalently link with targeting and
imaging ligands for subsequent cancer-cell targeting and imaging. The
Au DENPs linked with defined numbers of folic acid (FA) and fluores-
cein isothiocyanate (FI) molecules are water soluble, stable, and biocom-
patible. In vitro studies show that the FA- and FI-modified Au DENPs
can specifically bind to KB cells (a human epithelial carcinoma cell line)
that overexpress high-affinity folate receptors and they are internalized
dominantly into lysosomes of target cells within 2 h. These findings dem-









Dendrimer-entrapped metal nanoparticles are of scien-
tific and technological interest because of their unique struc-
ture and functionality.[1–5] These nanoparticles have been
primarily used in catalysis,[6] optics,[7] and other applications
unrelated to biomedical sciences. The absence of biological
applications is largely due to the toxicity of these particles
and technical difficulties with their surface manipulation.
Dendrimer-entrapped metal nanoparticles (metal DENPs)
are usually prepared by reducing metal ions that have been
complexed with dendrimer templates.[2,4,6–8] Because of the
diameter of the dendrimer template, these particles are
always smaller than 3 nm.[6] While there are a few reports on
biological sensing using dendrimer-stabilized metal nanopar-
ticles (also called “interdendrimer nanoparticles”),[9,10] there
is no reported literature showing that these nanoparticles
can achieve specificity and selectivity in biological systems.
In a previous report, we demonstrated that dendrimer-
entrapped gold nanoparticles (Au DENPs) prepared using
amine-terminated fifth-generation poly(amido ACHTUNGTRENNUNGamine)
(PAMAM) dendrimers (G5·NH2) as templates can be sur-
face-modified with acetyl and hydroxyl groups, thereby sig-
nificantly reducing the toxicity of Au DENPs.[11] The ability
to chemically functionalize preformed Au DENPs without
significantly changing their sizes and size distributions led
us to develop Au DENPs as a multifunctional platform for
cancer-cell targeting, imaging, and treatment as we have car-
ried out with dendrimers.[12–15] It should be possible to visu-
alize Au DENP-based therapeutics in targeted cells and tis-
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sues because of the high electron-density contrast of the Au
atoms. Multifunctional Au DENPs may also be used for tar-
geted hyperthermia treatment of cancers through inductive
heating of cells that have internalized these particles.
Here we demonstrate that Au DENPs can be covalently
linked with targeting ligands and imaging molecules for
cancer-cell targeting and imaging. Au DENPs linked with
defined numbers of folic acid (FA) and fluorescein isothio-
cyanate (FI) molecules are water soluble, stable, and bio-
compatible. We show that the FA- and FI-modified Au
DENPs can specifically bind to KB cells (a human epithelial
carcinoma cell line) that overexpress high-affinity folate re-
ceptors and be internalized predominantly into lysosomes of
target cells within 2 h. These findings document a facile ap-
proach to use Au DENPs as a platform for the targeting
and imaging of cancer cells.
2. Results
2.1. Surface Modification, Characterization, Stability, and
Toxicity of Au DENPs
Au DENPs were prepared using G5·NH2 dendrimers as
templates according to previously described proce-
dures.[8,11,16] The formed Au DENPs are relatively monodis-
perse with a mean diameter of 2.1 nm.[11] It is worthwhile to
note that the size of the synthesized pristine Au DENPs is
larger than those particles prepared by Crooks and co-work-
ers.[16] This is presumably due to the difference in the prepa-
ration conditions, such as the metal atom/dendrimer molar
ratio, type of dendrimer templates, as well as the reaction
solvents used. The approach to functionalize Au DENPs
with defined numbers of targeting molecules (e.g., FA) and
dyes (e.g., FI) is slightly modified from the methods that are
used to functionalize dendrimers (without entrapped metal
nanoparticles) for targeting and imaging of cancer cells
(Figure 1).[13, 17,18] One of the key steps in the preparation of
FA- and FI-modified Au DENPs is to keep the surface
charge on the particles neutral in order to avoid toxicity and
nonspecific binding. This can be accomplished by a final
acetylation step to convert the remaining amine groups of
G5·NH2 dendrimers to acetamides (Figure 1). Zeta-potential
measurements show that after the final acetylation step, the
surface potentials of the formed {(Au0)51.2-G5-FI5-Ac} (x=
1.11 mV) and {(Au0)51.2-G5-FI5-FA5-Ac} (x=2.30 mV)
DENPs (Ac denotes acetyl) are close to neutral, indicating
the success of the acetylation reaction. The slightly negative
charges on both DENPs may derive from the deprotonated
carboxyl groups in both FI and FA moieties being conjugat-
ed. The number of FI and FA moieties conjugated onto
each Au DENP can be estimated by comparing the differ-
ence between the integration values of the 1H NMR signals
associated with the dendrimers and the FI and FA moieties,
as we did for dendrimer (without entrapped Au nanoparti-
cles) conjugation (Figure S1 in the Supporting Informa-
tion).[13, 19] The average number of FI and FA moieties con-
jugated onto each Au DENP was estimated to be 4.0 and
4.5, respectively.
Transmission electron microscopy (TEM) images show
that the sizes of {(Au0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-
FA5-Ac} DENPs are 3.40.6 nm and 3.20.7 nm (Fig-
ure 2a–d), respectively. The larger sizes compared to those
of pristine {(Au0)51.2-G5·NH2} DENPs (2.1 nm)
[11] may be be-
cause of multiple surface modifications, which facilitate Ost-
wald ripening of the Au DENPs. UV/Vis spectroscopy (Fig-
ure 2e) verified the conjugation of FI and FA moieties onto
Au DENPs. The {(Au0)51.2-G5-FI5-FA5-Ac} DENPs show
characteristic absorption peaks at both 500 nm and 280 nm
for the FI and FA moieties, respectively, while only the
characteristic absorption peak at 500 nm related to the FI
moiety is observed for the {(Au0)51.2-G5-FI5-Ac} DENPs. In
addition, a band representing an overlap of the surface plas-
mon resonance of Au DENPs (510 nm) with the absorption
of FI moieties is also observed. The functionalized Au
DENPs are stable in both water solution and cell-culture
medium, and no precipitation of the solution appeared even
after periods of storage as long as 9 months (a photograph
of the aqueous solutions of {(Au0)51.2-G5-FI5-Ac} and
{(Au0)51.2-G5-FI5-FA5-Ac} DENPs is shown in Figure S2 in
the Supporting Information).
The stability of functionalized Au DENPs was also stud-
ied under different conditions. The UV/Vis spectra of
{(Au0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs
dissolved in PBS buffer (Figure S3a, Supporting Informa-
tion) do not show significant changes compared to those of
the corresponding Au DENPs dissolved in water (Fig-
ure 2e), indicating that the ionic strength of the PBS buffer
Figure 1. Schematic representation of the reactions involved in modi-
fying Au DENPs for cancer-cell targeting and imaging.
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does not have an impact on the stability of the Au DENPs.
In addition, in solutions with pH values ranging from 5.3 to
8.4, both {(Au0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac}
DENPs show similar absorbance profiles to those of the cor-
responding Au DENPs dissolved in water (Figure S3b and
S3c), suggesting that the functionalized Au DENPs are
stable and no aggregation is seen under the pH conditions
studied. The morphologies of the functionalized Au DENPs
at different pH conditions were also studied by TEM imag-
ing (data not shown), further confirming that the Au
DENPs are stable and have similar sizes and size distribu-
tions. This is consistent with our previous results for synthet-
ically modified Au DENPs.[11] A 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay of KB
cells shows that the functionalized Au DENPs are not cyto-
toxic even at concentrations up to 2000 nm (Figure 2 f), im-
plying that the final acetylation step creates biocompatible
nanoparticles.
Figure 2. Characterization and toxicity test of functionalized Au DENPs. a, c) TEM images of the functionalized {(Au0)51.2-G5-FI5-Ac} and
ACHTUNGTRENNUNG{(Au0)51.2-G5-FI5-FA5-Ac} DENPs, respectively. b,d) Size-distribution histograms of {(Au
0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs, respec-
tively. e) UV/Vis spectra of the starting {(Au0)51.2-G5·NH2} and functionalized {(Au
0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs. f) MTT
assay of KB cell viability after treatment with {(Au0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs for 24 h. The data are expressed as
mean  standard deviation.
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2.2. Molecular-Dynamics Simulations of Surface-Modified
Au DENPs
Molecular-dynamics simulations of pristine {(Au0)51.2-
G5·NH2} DENPs and FA- and FI-modified {(Au
0)51.2-G5-
FI5-FA5-Ac} DENPs were performed using conditions found
to be optimal in previous studies to predict PAMAM den-
drimers.[18, 20] The dendrimer as a whole presents an extend-
ed structure because of the positively charged primary
amines at pH 7, while easily containing the 2 nm Au sphere
within (one of the equilibrated {(Au0)51.2-G5·NH2} DENP
configurations is shown in Figure S4a of the Supporting In-
formation). In order to incorporate the TEM data in the
simulation (Figure 2), we used a 3-nm-diameter Au sphere
for the {(Au0)51.2-G5-FI5-FA5-Ac} DENP model. We ran-
domly selected five primary amine groups for FI and anoth-
er five for FA modification from the readily available pri-
mary amines of the Au DENP configuration. After attach-
ing FI and FA molecules to the model, we modified the re-
maining primary amines into acetylated terminal groups.
Figure S4b shows the potential energy changes over the sim-
ulation times for the {(Au0)51.2-G5·NH2} DENP and
{(Au0)51.2-G5-FI5-FA5-Ac} DENP models, respectively. Simu-
lations were well equilibrated before the simulation time at
40 ps. One of the equilibrated configurations of {(Au0)51.2-
G5-FI5-FA5-Ac} DENP containing a 3 nm Au sphere is
shown in Figure S4c (Supporting Information). The neutral-
ized dendrimer shows a collapsed shape compared to the
pristine {(Au0)51.2-G5·NH2} DENPs seen in Figure S4a, but
the Au sphere is practically within the FA- and FI-modified
G5 dendrimer, even with a larger Au particle (3 nm).
Interestingly, most FA moieties (pink spheres in Fig-
ure S4c) extend substantially outward, thus becoming avail-
able for interaction with the folic acid receptors (FAR) on
the surface of the cells. Most FI moieties (green spheres in
Figure S4c) are distant from the Au sphere, minimizing the
fluorescence quenching effect with the Au. Figure S4d
shows the density distribution of all atoms comprising FA
(pink line) and FI (green line) from the center of mass of
the {(Au0)51.2-G5-FI5-FA5-Ac} DENP during 40 ps to 100 ps
simulation times. The dotted line represents the mean
radius of gyration (22.30.04 H) of the {(Au0)51.2-G5-FI5-
FA5-Ac} DENPs during the same simulation period. More
than half of the FA moieties reside outside of the radius of
gyration during these simulation times, confirming the avail-
ability of FA moieties for the binding with FAR on the sur-
face of targeted cells.
2.3. Targeting of Functionalized Au DENPs to Cancer Cells
Overexpressing Folate Receptors
FA has been extensively investigated for targeting vari-
ous cancer cells, including ovary, kidney, uterus, testis, brain,
colon, lung, and myelocytic blood that overexpress
FAR.[21–24] The high-affinity FAR for FA (Kd=0.1–1 nm) af-
fords specific binding and internalization of FA-modified
nanoparticles to cancer cells in the presence of normal cells
through receptor-mediated endocytosis. KB cells were se-
lected for the specific binding with functionalized Au
DENPs. KB cells with both high and low levels of FAR
were respectively incubated with {(Au0)51.2-G5-FI5-FA5-Ac}
and {(Au0)51.2-G5-FI5-Ac} DENPs for 1 h. Figure 3a–d shows
the flow cytometric analyses of KB cells that express both
high and low levels of FAR after exposure to functionalized
Au DENPs (25 nm) for 1 h. It is clear that the treatment of
KB cells expressing a high level of FAR with {(Au0)51.2-G5-
FI5-FA5-Ac} DENPs results in a significant increase in the
fluorescence signal within the cells. In contrast, the same
KB cells treated with {(Au0)51.2-G5-FI5-Ac} DENPs without
FA display a similar fluorescence signal to cells treated with
PBS buffer (Figure 3a), suggesting no binding of the
{(Au0)51.2-G5-FI5-Ac} DENPs. KB cells with a low level of
FAR treated with either {(Au0)51.2-G5-FI5-FA5-Ac} or
{(Au0)51.2-G5-FI5-Ac} DENPs show a similar fluorescence in-
tensity to the PBS control (Figure 3b). These results indi-
cate that the specificity of {(Au0)51.2-G5-FI5-FA5-Ac} DENPs
binding to KB cells is restricted to cells containing high
levels of FAR. The cellular uptake of the FA-functionalized
Au DENPs shows a dose-dependent trend, with saturation
and 50% binding occurring at approximately 50 nm and
18 nm, respectively (Figure 3c), which is comparable with
the binding capacity of FA-modified G5 dendrimers.[14] For
KB cells with a low level of FAR, neither {(Au0)51.2-G5-FI5-
FA5-Ac} nor {(Au
0)51.2-G5-FI5-Ac} DENPs show any signifi-
cant binding, even at concentrations up to 300 nm (Figure 3d).
The conjugation of the FI moiety onto Au DENPs also
enables confocal microscopic imaging of the intracellular
uptake. Figure 3e–g shows that only KB cells with a high
level of FAR treated with FA-modified {(Au0)51.2-G5-FI5-
FA5-Ac} DENPs display fluorescence signals, which is asso-
ciated with the specific internalization of {(Au0)51.2-G5-FI5-
FA5-Ac} DENPs into the cytoplasm of the cells (Figure 3 g).
In contrast, the same KB cells treated with {(Au0)51.2-G5-
FI5-Ac} DENPs without FA modification do not show any
fluorescence signals (Figure 3 f), which is the same as for
KB cells treated with PBS buffer (Figure 3e). This result
suggests that the binding and intracellular uptake do not
occur in the cells treated with non-FA modified Au DENPs.
By using the TEM imaging technique, we can clarify the
distribution of functionalized Au DENPs in different subcel-
lular compartments inside targeted cells. Upon 2 h incuba-
tion of functionalized Au DENPs, the FA-modified
{(Au0)51.2-G5-FI5-FA5-Ac} DENPs were predominantly lo-
cated in the lysosomes of KB cells with high-level FAR ex-
pression (Figure 4a and 4b). We also observed that a small
portion of {(Au0)51.2-G5-FI5-FA5-Ac} DENPs situated in va-
cuoles and the nucleus (Figures S5 and S6 of the Supporting
Information). However, we did not see any uptake of the
{(Au0)51.2-G5-FI5-Ac} DENPs without FA modification in
the lysosomes of the same KB cells (Figure 4c). A very
small quantity of {(Au0)51.2-G5-FI5-Ac} DENPs were ob-
served in the vacuoles of some cells (Figure S7), but this
was undetectable using confocal microscopy. This uptake is
believed to be associated with diffusion-driven nonspecific
binding since control cells not exposed to Au DENPs show
no internalized metal nanoparticles (images not shown).
The TEM studies highlighted the high specificity of FA-
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modified Au DENPs for targeting KB cells with high-level
FAR expression, and corroborate the confocal imaging
data.
3. Discussion
The well-defined structure and composition, as well as
the narrow polydispersity of dendrimers lead to their exten-
sive applications for targeted cancer therapeutics.[12–14,25]
However, dendrimer-based therapeutics do not allow the
direct imaging of subcellular compartments because of the
low electron-density contrast. One major advantage of using
functionalized Au DENPs to
image cancers is their ability
to differentiate cancer cells
from surrounding cells or tis-
sues by using contrast agents
with high electron density.
The use of Au DENPs also
aids in understanding the
mechanism for targeted drug
delivery and therapeutics,
using dendrimer-based nano-
devices. In addition, it is pos-
sible to use Au DENPs for
laser hyperthermia cancer
therapeutics through induc-




shows that Au DENPs can
be modified through reac-
tions with dendrimer periph-
eral groups, while keeping a
similar particle size and size
distribution to the pristine
amine-terminated Au
DENPs. As compared to
general short-range organic
reactions, the modification of
FI and FA molecules on the
G5 dendrimer surface in the
presence of Au nanoparticles
may introduce strong hydro-
gen-bonding interactions be-
tween the linked moieties
and water in solution. There-
fore, the dendrimer skeletons
that entrap Au nanoparticles
may be more open and facili-
tate the Ostwald ripening
process, thereby leading to
an increase in size of the Au
nanoparticles (3.2 nm for
{(Au0)51.2-G5-FI5-FA5-Ac}
versus 2.1 nm for {(Au0)51.2-
G5·NH2} DENPs, Figure 2).
The increase of Au-nanoparticle size of the DENP structure
does not have an impact on the stability of the particles in
PBS buffer and in the pH ranges (5.3–8.4) studied (Fig-
ure S3). Our molecular-dynamics simulation studies show
that the attached FI moieties on Au DENP surfaces are dis-
tant from the Au nanoparticles, which minimize the fluores-
cence quenching effect with metal Au, while the attached
FA moieties extend substantially outward, thus becoming
available for interaction with FAR on the surface of target
cells (Figure S4). These properties allow the Au DENPs to
perform perfectly in the binding and detection of cancer
cells through receptor–ligand interactions (Figure 3 and
Figure 4).
Figure 3. Flow cytometric and confocal microscopy studies of the binding of functionalized Au DENPs
with KB cells. a,b) Binding of {(Au0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs (25 nm) with KB
cells with high and low levels of FAR, respectively: 1) PBS control; 2) {(Au0)51.2-G5-FI5-Ac}; 3) {(Au
0)51.2-
G5-FI5-FA5-Ac}. c,d) Dose-dependent binding of {(Au
0)51.2-G5-FI5-Ac} and {(Au
0)51.2-G5-FI5-FA5-Ac} DENPs
with KB cells expressing high and low levels of FAR, respectively. e–g) Confocal microscopy images of
KB cells with high-level FAR treated with PBS buffer (e), {(Au0)51.2-G5-FI5-Ac} (25 nm) (f), and {(Au
0)51.2-G5-
FI5-FA5-Ac} (25 nm) (g) DENPs for 2 h, respectively.
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4. Conclusions
In summary, we demonstrate that preformed Au DENPs
prepared using amine-terminated G5·NH2 dendrimers as
templates can be covalently linked with FA and FI moieties
through reaction with the terminal amines of G5·NH2 den-
drimer templates in the presence of entrapped Au nanopar-
ticles. The functionalized Au DENPs are stable, biocompat-
ible, and can be used for specific targeting and imaging of
cancer cells with overexpressing FAR. We are currently
doing extensive in vivo experiments to verify the in vivo per-
formance of the functionalized Au DENPs. This approach
to functionalizing Au DENPs may be applied to various
other biological ligands (e.g., sugars, peptides, proteins, and
antibodies) for targeting and imaging various biological sys-
tems. We also anticipate that drug molecules can be conju-
gated onto Au DENPs, thereby providing an approach for
imaging and targeted treatment to various forms of cancers
and biological systems.
5. Experimental Section
Synthesis and functionalization of Au DENPs: The procedure
to synthesize Au DENPs is adopted from those previously report-
ed in the literature, but with slight variations.[8,16] Details can be
found in our previous report.[11] The Au DENPs were prepared
using sodium borohydride reduction chemistry with the dendri-
mer terminal amine/gold atom molar ratio at 1:0.4. Briefly, a
HAuCl4 solution (118.2 mm, 5 mL) was added into a G5·NH2 den-
drimer (Dendritech, Midland, MI) aqueous solution (0.577 mm,
20 mL) under vigorous stirring. After 30 min, a NaBH4 solution
(197 mm, 6 mL) dissolved in a water/methanol (2:1 in volume)
mixture was slowly added to the gold salt/dendrimer mixture
while stirring. The reaction mixture turned a deep-red color
within a few seconds after addition of the NaBH4 solution. The
stirring was continued for 2 h to complete the reaction. The reac-
tion mixture was extensively dialyzed against water (six times,
4 L) for 3 days to remove the excess reactants, followed by lyo-
philization to obtain the product {(Au0)51.2-G5·NH2} DENPs.
Five molar equivalents of FI (3.27 mg, 8.4 mmol; Aldrich) dis-
solved in dimethylsulfoxide (DMSO; 5 mL) were added dropwise
to a solution of {(Au0)51.2-G5·NH2} DENPs (61.19 mg, 1.68 mmol)
in DMSO (10 mL) under a nitrogen atmosphere with vigorous
magnetic stirring. After 24 h, the reaction mixture (15 mL) was
divided into two aliquots with equal volume (7.5 mL). For ali-
quot 1, the FI-labeled {(Au0)51.2-G5·NH2} DENPs were acetylated
to convert the remaining amino groups of the G5 dendrimer to
acetamide groups according to a procedure in the literature.[26]
Briefly, aliquot 1 was put together with triethylamine (37.4 mg,
0.37 mmol) and mixed well, followed by dropwise addition of an
acetic anhydride solution (37.74 mg, 0.37 mmol) under vigorous
stirring. After 24 h, the reaction mixture was extensively dialyzed
against PBS buffer (three times, 4 L) and water (three times, 4 L)
using a regenerated cellulose dialysis membrane (MWCO=
10000; Fisher) for 3 days to remove the excess reactants and
byproducts, followed by lyophilization to obtain the product
{(Au0)51.2-G5-FI5-Ac} DENPs (yield=59.3%).
1H NMR (500 MHz,
D2O) d [ppm]: 6.99 (bs, 2H), 6.39 (bs, 4H), 3.10 (s, 174H), 2.67
(s, 107H), 2.43 (s, 73H), 2.25 (s, 118H), 1.78 (s, 102H). The
number of dendrimer protons was extrapolated based on the in-
tegration values relative to those for FI protons. The same situa-
tion applies for the FA modification with Au DENPs (see below).
For aliquot 2, the FI-labeled {(Au0)51.2-G5·NH2} DENPs were
further modified with FA (Aldrich) according to a previous proce-
dure with a slight modification.[15] Briefly, a 5-molar equivalent
of FA (1.90 mg, 4.3 mmol; Aldrich) in DMSO (2 mL) was mixed
with a DMSO solution (2 mL) containing N-(3-dimethylamino-
propyl)-N’-ethylcarbodiimide hydrochloride (EDC) (34.8 mmol,
6.67 mg; Aldrich) and stirred for 3 h. This process activated the
g-carboxylic acid of FA for further reaction with FI-labeled
{(Au0)51.2-G5·NH2} DENPs. The activated FA solution (4 mL in
DMSO) was added to aliquot 2-FI-labeled {(Au0)51.2-G5·NH2}
DENPs and stirred for 3 days. Then, the FI- and FA-modified
Figure 4. TEM images of cellular uptake of Au DENPs. a–c) TEM images of KB cells with high-level FAR treated with {(Au0)51.2-G5-FI5-FA5-Ac} (a,b)
and {(Au0)51.2-G5-FI5-Ac} DENPs (c) for 2 h, respectively. b) A magnified area of the lysosome of the same cell shown in (a). In (c), arrows indi-
cate the lysosome morphology. The concentration for both Au DENPs is maintained at 50 nm.
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{(Au0)51.2-G5·NH2} DENPs were further acetylated to neutralize the
remaining amino groups of G5 dendrimers as described above,
followed by extensive dialysis against PBS buffer (three times,
4 L) and water (three times, 4 L) for 3 days to remove the excess
reactants and byproducts and lyophilization to obtain the prod-
uct {(Au0)51.2-G5-FI5-FA5-Ac} DENPs (yield=77.1%).
1H NMR
(500 MHz, D2O) d [ppm]: 8.60 (bs, 1H), 7.46 (bs, 2H), 6.93 (bs,
2H), 6.50 (bs, 2H), 6.37 (bs, 4H), 3.09 (s, 174H), 2.66 (s,
107H), 2.48 (s, 73H), 2.23 (s, 118H), 1.78 (s, 102H).
Simulation conditions : All dendrimer models were built on
an Onyx workstation (Silicon Graphics, Inc.; Mountain View, CA)
using the Insight II software package (Accelrys, Inc.; San Diego,
CA). All primary amines were protonated and carboxyl groups de-
protonated to simulate pH 7 conditions. Since a Au crystal com-
prises a cubic close-packed structure, we prepared Au spheres
with such a structure and applied constraints to fix their struc-
tures during the simulations. After the steepest descent minimi-
zation process for 5000 steps, MD simulations were performed
at 1000 K for 5 ps followed by 100 ps runs (50 ps for the case of
PAMAM dendrimer alone) with a 1 fs step at 300 K, using a con-
sistent valence force field (CVFF) in the Insight II software. The
potential energies stabilized much earlier than 50 ps. The total
potential energy function (Utotal) for MD calculations includes
bonded terms (Ubonded: empirical potential energy terms describ-
ing chemical bonds) and nonbonded interactions (Unonbonded),
which is described as
Utotal ¼ Ubonded þ Unonbonded ¼ Ubonded þ ULennardJones














where e is the minimum energy of the Lennard–Jones potential,
s the distance yielding a minimum Lennard–Jones potential, q
the partial charge on the atom, D the dielectric constant (1 for
vacuum), r the distance between i and j, and i, j are nonbonded
atom pairs. We used the dielectric constant D= r, so that it can
be a function of r. No long-range interaction cut-off was used,
based on previous findings.[20]
Instrumentation for characterization of functionalized Au
DENPs: 1H NMR spectra of Au DENPs were recorded on a Bruker
DRX 500 nuclear magnetic resonance spectrometer. Samples
were dissolved in D2O before NMR measurements. UV/Vis spec-
tra were collected using a Perkin–Elmer Lambda 20 UV/Vis spec-
trometer. All samples were dissolved in water at a concentration
of 1 mgmL1. Zeta-potential measurements were performed
using a Malvern Zetasizer Nano ZS model ZEN3600 (Worcester-
shire, UK) equipped with a standard 633 nm laser. A JEOL 2010F
analytical electron microscope was used at 200 kV with an EDS
system attached. A 5 mL aqueous solution of Au DENPs
(1 mgmL1) was dropped onto a carbon-coated copper grid and
air dried before measurements.
Cell cultures and biological evaluation: The KB cells (ATCC,
CLL17, Rockville, MD) were continuously grown in two 24-well
plates, one in FA-free media and the other in regular RPMI 1640
cell culture medium (Gibco/BRL, Gaithersburg, MD) supplement-
ed with penicillin (100 unitsmL1; Sigma, St. Louis, MO), strep-
tomycin (100 mgmL1; Sigma), 10% heat-inactivated FBS, and
2.5 mm FA. The cells grown in FA-free media express high-level
FAR, while the cells grown in FA-containing media express low-
level FAR.
MTT cytotoxicity assay: An MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay was used to quantify
the viability of cells. Briefly, 5K104 KB cells per well were
seeded into a 96-well plate. After overnight incubation, function-
alized Au DENPs at concentrations ranging from 0 to 2 mm in
PBS (pH 7.4) were added. After 24 h incubation with Au DENPs
at 37 8C, the MTT reagent in PBS solution was added. The assays
were carried out according to the manufacturer’s instructions.
For each concentration of Au DENPs, five wells of cells were ana-
lyzed.
Flow cytometry analysis: Approximately 2K106 cells per well
were seeded in 12-well plates the day before the experiments.
An hour before initiating an experiment, the cells were rinsed
four times with serum-free and FA-deficient RPMI 1640 media.
Functionalized Au DENPs were added in the final concentrations
of 0–300 nm. After 1 h incubation with the functionalized Au
DENPs, KB cells with both high- and low-level FAR expression
were trypsinized (Gibco/BRL, Gaithersburg, MD) and suspended
in PBS containing 0.1% bovine serum albumin (Sigma, St.
Louis, MO) and analyzed using a Becton Dickinson FACScan ana-
lyzer. The FL1-fluorescence of 10000 cells was measured, and
the mean fluorescence of gated viable cells was quantified.
Confocal microscopy: Confocal microscopic analysis was per-
formed in cells plated on a plastic cover-slip using an Olympus
FluoView 500 laser scanning confocal microscope (Melville, NY).
FI fluorescence was excited with a 488 nm argon blue laser and
emission was measured through a 505–525 barrier filter. The
optical section thickness was set at 5 mm. The cells were incu-
bated with functionalized Au DENPs for 2 h, followed by rinsing
with PBS buffer. The nuclei were counterstained with 1 mgmL1
of Hoescht33342, using a standard procedure. Samples were
scanned using a 60K water-immersion objective lens and magni-
fied with FluoView software.
Transmission electron microscopy (TEM): The uptake of func-
tionalized Au DENPs was further examined by a Phillips CM 100
electron microscope operating at a voltage of 60 kV. Images
were recorded using a Hamamatsu digital camera controlled by
AMT (advance microscopy technology) software. The specimens
were prepared according to the following procedures. The KB
cells with high-level FAR were aliquoted in 5 mL tubes at a con-
centration of 1K106 cellsmL1. After overnight growth at 37 8C,
the medium was removed and 2% FBS solution containing
50 nm of functionalized Au DENPs was added; the incubation
was carried out for 2 h at 37 8C. Then, the medium was removed
and cells were washed with Sorenson buffer and fixed at room
temperature for 1 h using 2.5% of glutaraldehyde in Sorenson
buffer. The cells were rinsed 3 times with Sorenson buffer, resus-
pended in the same medium, and post-fixed using 1.0%
osmium tetroxide for 1 h. After additional washing in buffer, the
cells were dehydrated in a series of ethanol solutions of 30%,
50%, 70%, 95%, and 100%. The samples were further infiltrat-
ed using the following sequence of mixtures of 100% ethanol
and Epon: 3 parts of ethanol + 1 part resin (for 1 h), 1 part of
ethanol + 1 part resin (for 1 h), 1 part of ethanol + 3 parts
resin (overnight), full-strength resin (4 h), and full-strength resin
(overnight). After the third change of resin, polymerization was
performed and sections with the thickness of 75 nm were ob-
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tained using a Reichart Ultramicrotome. Sections were mounted
on 200-mesh copper grids before TEM measurements.
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